 1. the absence of clinically significant illness and surgery within 12 weeks prior to administration. Subjects vomiting within 24 hours pre-administration will be carefully evaluated for upcoming illnessdisease. Inclusion pre-administration is at the discretion of the Qualified Investigator. 